|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S1
|
$48,687
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S2
|
$85,299
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
|
1U54CA221704-01A1
|
$1,050,067
|
OGUNWOBI, OLORUNSEUN
|
HUNTER COLLEGE
|
|
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
|
1R01CA227466-01
|
$699,062
|
ZIV, ELAD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ1) Epigenetic effects of the premalignant field
|
5R01CA208620-03
|
$415,599
|
TERADA, LANCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
|
5R01CA219893-02
|
$427,989
|
GHOSH, MOUMITA
|
NATIONAL JEWISH HEALTH
|
|
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
|
5R01CA205608-03
|
$346,909
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
|
1R01CA219637-01A1
|
$281,441
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
|
1R01CA231112-01
|
$576,627
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
5R01CA208642-03
|
$352,275
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
|
5R01CA208634-03
|
$560,277
|
JURECIC, ROLAND
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
|
5R01CA206028-03
|
$342,846
|
GEWIRTZ, DAVID
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
3P20CA202923-04S1
|
$32,990
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202923-04
|
$54,305
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
|
1U54CA221705-01A1
|
$1,671,024
|
MA, GRACE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-04
|
$969,219
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
2/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
5P20CA202921-04
|
$289,031
|
SPICER, PAUL
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-09
|
$1,003,901
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-04
|
$789,845
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202997-04
|
$1,566,061
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A Case-Control Study of Lung Cancer among Non-smoking Women in Xuan Wei and Fu
|
ZIA CP010121 10349
|
$53,686
|
Lan, Qing
|
DCEG (NCI)
|
|
A cohort mortality study with a nested case-control study of lung cancer and dies
|
ZIA CP010120 02091
|
$582,330
|
Silverman, Debra
|
DCEG (NCI)
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$79,723
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers
|
5F32CA206247-02
|
$63,034
|
WAGNER, ALEX
|
WASHINGTON UNIVERSITY
|
|
A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules
|
2R44CA203058-02A1
|
$529,613
|
MENG, XIN
|
INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-05S1
|
$256,320
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
|
1R01CA223495-01A1
|
$454,077
|
ROSSMAN, KENT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
|
5R01CA184173-04
|
$363,342
|
REN, LEI
|
DUKE UNIVERSITY
|
|
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath
|
1R21CA229057-01
|
$226,587
|
FU, XIAO-AN
|
UNIVERSITY OF LOUISVILLE
|
|
A model for predicting response to PD-1 inhibitors in NSCLC
|
5R01CA208403-02
|
$635,258
|
GARON, EDWARD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A model of smoking relapse: an assessment of stress, discrimination and socioeconomic status
|
3R01CA190329-04S1
|
$115,391
|
WETTER, DAVID
|
UNIVERSITY OF UTAH
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer
|
1K08CA234335-01
|
$196,414
|
THOMPSON, JEFFREY
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
|
5R01CA210625-02
|
$542,711
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A new imaging approach to radiotherapy planning for lung cancer
|
5R01CA193050-04
|
$577,910
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
|
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
|
5R01CA191489-04
|
$380,278
|
NGUYEN, DON
|
YALE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|